[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551088":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":26,"locations":26,"responsibleParty":27,"collaborators":26,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":35,"eligibilityCriteria":36,"healthyVolunteers":31,"sex":37,"minAge":38,"maxAge":39,"enrollmentInfo":40,"targetDuration":26,"studyType":43,"phases":44,"briefSummary":46,"conditions":47,"keywords":49,"overallStatus":52,"whyStopped":26,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":26},{"fullName":5,"class":6},"Sixth Affiliated Hospital, Sun Yat-sen University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Nerve block","EXPERIMENTAL","The superior hypogastric plexus block in this group will contain 20 mL of 0.75% ropivacaine hydrochloride.",[13],"Procedure: Superior hypogastric plexus block",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo block","PLACEBO_COMPARATOR","The superior hypogastric plexus block in this group will contain 20 mL of 0.9% normal saline.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Superior hypogastric plexus block","Prior to the laparoscopic hysterectomy and any additional procedures, the superior hypogastric plexus block will be performed on all the patients. The block will contain 20 mL of 0.75% ropivacaine hydrochloride or 0.9% normal saline. The injection will be performed by tenting the presacral peritoneum, aspirating with a laparoscopic needle-tip syringe to ensure extravascular placement, and injecting the block.",[9,15],[9],null,{"type":28,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100551088","superior-hypogastric-plexus-block-during-laparoscopic-hysterectomy-subtle-100551088",false,"NCT06455540","SUperior Hypogastric Plexus Block During Laparoscopic hysterEctomy (SUBTLE)","Superior Hypogastric Plexus Block During Laparoscopic Hysterectomy","SUBTLE","Inclusion Criteria:\n\n* Able to provide informed consent\n* Undergoing laparoscopic hysterectomy for benign indications\n\nExclusion Criteria:\n\n* Planned procedure that requires dissection of the presacral space\n* Allergy to block medication (s)\n* Known or suspected malignancy","FEMALE","18 Years","70 Years",{"count":41,"type":42},198,"ESTIMATED","INTERVENTIONAL",[45],"NA","This trial sest to assess the efficacy of a superior hypogastric plexus block (SHPB) for quality of recovery after a laparoscopic hysterectomy.",[48],"Hysterectomy",[48,50,51],"Minimally invasive surgery","Quality of recovery","NOT_YET_RECRUITING","2024-06-13",{"date":55,"type":56},"2024-06-14","ACTUAL",{"date":58,"type":42},"2024-07-16",{"date":60,"type":42},"2025-12-31",{"name":5,"class":6}]